Our results demonstrated that the expression of several lncRNAs was affected by the presence of a MED12 mutation, which could be contributing to the differences in tumor size and progression in mutated leiomyomas as compared with non-mutated leiomyomas and merits further investigation. The gene discussed is MED12; the disease is neoplasm.